WO2006102370A3 - Functional brain mri mapping as a marker in cns diseases and disorders - Google Patents
Functional brain mri mapping as a marker in cns diseases and disorders Download PDFInfo
- Publication number
- WO2006102370A3 WO2006102370A3 PCT/US2006/010324 US2006010324W WO2006102370A3 WO 2006102370 A3 WO2006102370 A3 WO 2006102370A3 US 2006010324 W US2006010324 W US 2006010324W WO 2006102370 A3 WO2006102370 A3 WO 2006102370A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disorders
- marker
- cns diseases
- brain mri
- functional brain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Physiology (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Educational Technology (AREA)
- Neurosurgery (AREA)
- Social Psychology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
The invention relates in some aspects to methods of using functional connectivity brain mapping to assess predictive markers of selecting therapeutic agents, therapies, and/or treatment regimens based on predictive markers of CNS diseases that are determined using functional connectivity brain mapping. The methods of the invention are also useful for predicting whether a subject will or will not respond to a particular therapeutic agent or therapy.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66404705P | 2005-03-22 | 2005-03-22 | |
US60/664,047 | 2005-03-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006102370A2 WO2006102370A2 (en) | 2006-09-28 |
WO2006102370A3 true WO2006102370A3 (en) | 2008-10-23 |
Family
ID=37024549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/010324 WO2006102370A2 (en) | 2005-03-22 | 2006-03-22 | Functional brain mri mapping as a marker in cns diseases and disorders |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006102370A2 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6684105B2 (en) | 2001-08-31 | 2004-01-27 | Biocontrol Medical, Ltd. | Treatment of disorders by unidirectional nerve stimulation |
US7778711B2 (en) | 2001-08-31 | 2010-08-17 | Bio Control Medical (B.C.M.) Ltd. | Reduction of heart rate variability by parasympathetic stimulation |
US8571653B2 (en) | 2001-08-31 | 2013-10-29 | Bio Control Medical (B.C.M.) Ltd. | Nerve stimulation techniques |
US7885709B2 (en) | 2001-08-31 | 2011-02-08 | Bio Control Medical (B.C.M.) Ltd. | Nerve stimulation for treating disorders |
US7974693B2 (en) | 2001-08-31 | 2011-07-05 | Bio Control Medical (B.C.M.) Ltd. | Techniques for applying, configuring, and coordinating nerve fiber stimulation |
US7904176B2 (en) | 2006-09-07 | 2011-03-08 | Bio Control Medical (B.C.M.) Ltd. | Techniques for reducing pain associated with nerve stimulation |
US8036745B2 (en) | 2004-06-10 | 2011-10-11 | Bio Control Medical (B.C.M.) Ltd. | Parasympathetic pacing therapy during and following a medical procedure, clinical trauma or pathology |
US8204591B2 (en) | 2002-05-23 | 2012-06-19 | Bio Control Medical (B.C.M.) Ltd. | Techniques for prevention of atrial fibrillation |
US8320647B2 (en) | 2007-11-20 | 2012-11-27 | Olea Medical | Method and system for processing multiple series of biological images obtained from a patient |
JP5614599B2 (en) * | 2010-12-06 | 2014-10-29 | 国立大学法人 岡山大学 | Method and apparatus for confirming presence or absence of onset of dementia |
CN102138782A (en) * | 2011-03-10 | 2011-08-03 | 电子科技大学 | Brain functional effective connection analyzing method |
US9370660B2 (en) | 2013-03-29 | 2016-06-21 | Rainbow Medical Ltd. | Independently-controlled bidirectional nerve stimulation |
CA2969425A1 (en) * | 2014-12-01 | 2016-06-09 | The Feinstein Institute For Medical Research | Use of striatal connectivity patterns for evaluating antipsychotic agents |
US10105540B2 (en) | 2015-11-09 | 2018-10-23 | Bluewind Medical Ltd. | Optimization of application of current |
CN105249964B (en) * | 2015-11-10 | 2017-12-22 | 东南大学 | Appraisal procedure is rebuild based on magneticencephalogram and the multi-modal brain function of diffusion tensor |
US10390766B2 (en) | 2017-01-16 | 2019-08-27 | General Electric Company | System and method for predicting an excitation pattern of a deep brain stimulation |
US10624588B2 (en) | 2017-01-16 | 2020-04-21 | General Electric Company | System and method for predicting an excitation pattern of a deep brain stimulation |
JP6722845B2 (en) * | 2017-10-03 | 2020-07-15 | 株式会社国際電気通信基礎技術研究所 | Discriminating apparatus, depressive symptom discriminating method, depressive symptom level determining method, depressive patient stratification method, depressive symptom therapeutic effect determining method, and brain activity training apparatus |
CN107967686B (en) * | 2017-12-27 | 2021-07-06 | 电子科技大学 | Epilepsy recognition device combining dynamic brain network and long-time and short-time memory network |
EP3776591A1 (en) * | 2018-03-28 | 2021-02-17 | Icahn School of Medicine at Mount Sinai | Systems and methods for processing connectivity values between sub-processing regions |
CN109330596B (en) * | 2018-11-15 | 2022-04-12 | 郑州轻工业学院 | Brain function connection dynamic variability measurement method based on time window analysis |
CN110246566A (en) * | 2019-04-24 | 2019-09-17 | 中南大学湘雅二医院 | Method, system and storage medium are determined based on the conduct disorder of convolutional neural networks |
US11733332B2 (en) | 2019-12-09 | 2023-08-22 | Nous Imaging, Inc. | Systems and method of precision functional mapping-guided interventional planning |
CN111755120B (en) * | 2020-06-29 | 2023-07-21 | 西南民族大学 | Cognitive disorder prediction method based on edge intelligence and multimode perception |
CN112686098B (en) * | 2020-12-15 | 2023-05-26 | 中国人民解放军战略支援部队信息工程大学 | Shape-Resnet-based method and system for processing signals of middle and high-grade vision areas of brain |
CN114533066B (en) * | 2022-04-28 | 2022-08-19 | 之江实验室 | Social anxiety assessment method and system based on composite expression processing brain network |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6400978B1 (en) * | 1999-10-29 | 2002-06-04 | The Mclean Hospital Corporation | Method and apparatus for detecting mental disorders |
US6434419B1 (en) * | 2000-06-26 | 2002-08-13 | Sam Technology, Inc. | Neurocognitive ability EEG measurement method and system |
-
2006
- 2006-03-22 WO PCT/US2006/010324 patent/WO2006102370A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6400978B1 (en) * | 1999-10-29 | 2002-06-04 | The Mclean Hospital Corporation | Method and apparatus for detecting mental disorders |
US6434419B1 (en) * | 2000-06-26 | 2002-08-13 | Sam Technology, Inc. | Neurocognitive ability EEG measurement method and system |
Also Published As
Publication number | Publication date |
---|---|
WO2006102370A2 (en) | 2006-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006102370A3 (en) | Functional brain mri mapping as a marker in cns diseases and disorders | |
HK1207821A1 (en) | Improved modalities for the treatment of degenerative diseases of the retina | |
HK1215960A1 (en) | Improved modalities for the treatment of degenerative diseases of the retina | |
WO2008051599A3 (en) | Combination therapies for treating alzheimer's disease using i. a. dimebon and dolepezil | |
HK1086480A1 (en) | Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor | |
NO20083002L (en) | Method for using CD40 binding compounds | |
AP2378A (en) | Sulfonamide derivatives for the treatment of diseases. | |
AP2359A (en) | Sulfonamide derivatives for the treatment of diseases. | |
PL1765388T3 (en) | Combination therapy for preventing or treating alzheimer's disease, and kit therefor | |
WO2008106646A3 (en) | Methods and formulations for topical gene therapy | |
WO2006011810A3 (en) | Mr imaging method for the discrimination between healthy and tumour tissue | |
WO2006122046A3 (en) | Vascular disease therapies | |
DE602005020209D1 (en) | System for the evaluation of cardiac disorders | |
WO2008048410A3 (en) | Diagnostic methods and genetic markers for alzheimer disease | |
IL177787A0 (en) | 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease | |
WO2006042137A3 (en) | Methods for identifying parkinson's disease therapeutics | |
WO2006135694A3 (en) | Uii-modulating compounds and their use | |
WO2007094027A3 (en) | Methods for the diagnosis of proliferative and/or conformational diseases | |
WO2005112568A3 (en) | Haplotype markers and methods of using the same to determine response to treatment | |
GB2442365B (en) | Methods of determining compounds useful in the treatment of bipolar disorders | |
WO2004107958A3 (en) | Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | |
WO2006136454A3 (en) | Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease | |
WO2006014958A3 (en) | Platelet activation markers as predictors of disease and of response to therapy and for monitoring therapeutic progress | |
WO2010068935A3 (en) | Small molecule immunomodulators for alzheimer's disease | |
PL1904060T3 (en) | Use of phthalocyanine derivates for the non-photodynamic treatment of diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06739204 Country of ref document: EP Kind code of ref document: A2 |